BETA-NMN; BETA-NICOTINAMIDE MONONUCLEOTIDE; BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE; 3-(aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium; B-NICOTINAMIDE MONONUCLEOTIDE; NMN
CAS:1094-61-7
Chemical Formula:C11H15N2O8P
Molecular Weight:334.22
Availability: R&D; Commercialization
⬤ CAS No.1094-61-7
⬤ Packaging type：20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | β-Nicotinamide Mononucleotide |
| CAS No. | 1094-61-7 |
| Chemical Formula | C11H15N2O8P |
| Molecular Weight | 334.22 |
| EINECS | 214-136-5 |
| Related Categories | Steroids; cosmetic raw materials; coenzyme and nucleotide raw materials; technical drug intermediates |
| Melting point | 166 °C(dec.) |
| Storage Conditions | -20°C |
| Solubility | Soluble in DMSO (slightly heated), methanol (slightly), water (slightly) |
| Form | Solid |
| Color | White to yellow |
| Merck | 13,6697 |
| BRN | 3570187 |
| Stability | Very hygroscopic |
| InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
| Customs Code | 2934999090 |
| WGK Germany | 3 |
| Application | Nicotinamide mononucleotide (β-NMN, NMN) is one of the key precursors of NAD+ and the product of the NAMPT reaction, which is converted into NAD+ by nicotinamide mononucleotide adenylate transferase. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
This article elucidates the mechanism of action of GLP-1, the clinical data—including real-world efficacy and side effects—of drugs approved as of 2025 and novel oral therapies, their applicable patient populations, and their impact on the pharmaceutical supply chain.
It clarifies the core differences between SGLT2 inhibitors and GLP-1 receptor agonists, covering their mechanisms, clinical advantages and representative products. It highlights Orforglipron, a breakthrough oral small-molecule GLP-1 agonist.
Master regulatory submission for pharmaceutical intermediates with DMF/CEP documentation best practices. Fix common deficiencies, align with FDA/EDQM guidelines, and streamline review processes.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
